XML 98 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
For financial reporting purposes, the components of income (loss) before income tax benefit were as follows:
For the Year Ended
(Dollars in Thousands)December 31, 2024December 31, 2023December 31, 2022
(Predecessor)
U.S. Domestic
$(75,928)$(7,708)$1,082 
Foreign(119,510)(308,629)(6,553)
Income (loss) before income tax benefit$(195,438)$(316,337)$(5,471)
Schedule of Components of Income Tax Expense (Benefit)
The following table presents the components of the Company’s income tax expense (benefit):
For the Year Ended
(Dollars in Thousands)December 31, 2024December 31, 2023December 31, 2022
(Predecessor)
Current income tax expense (benefit)
U.S. federal$613 $803 $320 
State and local1,230 170 224 
Foreign1,079 880 84 
$2,922 $1,853 $628 
Deferred income tax expense (benefit)
U.S. federal$(10,178)$(173)$(64)
State and local(10,111)(863)(31)
Foreign(3,766)(11,351)(6)
$(24,055)$(12,387)$(101)
Total income tax expense (benefit)
U.S. federal$(9,565)$630 $256 
State and local(8,881)(693)193 
Foreign(2,687)(10,471)78 
Total income tax expense (benefit)$(21,133)$(10,534)$527 
Schedule of Effective Income Tax Rate Reconciliation
The following table sets forth the reconciliation of the Company’s effective rate to the statutory rate:
For the Year Ended
(Dollars in Thousands)December 31, 2024December 31, 2023December 31, 2022
(Predecessor)
U.S. federal tax expense (benefit) at statutory rate$(41,042)21.0 %$(66,416)21.0 %$(1,149)21.0 %
State tax, net of federal benefit(9,065)4.7 %(1,119)0.4 %38 (0.7)%
Goodwill Impairment14,640 (7.6)%32,254 (10.2)%— — %
Exempt income— — %(6,524)2.1 %127 (2.3)%
Non-deductible Professional Fees653 (0.3)%3,616 (1.1)%— — %
Change in fair value of warrant liability— — %2,702 (0.9)%— — %
Change in fair value of contingent consideration(6,129)3.2 %(5,500)1.7 %— — %
Other Permanent differences
1,631 (0.8)%— %(0.1)%
Prior period adjustments
49 — %(246)0.1 %(2)— %
Change in Valuation Allowance10,074 (5.2)%28,700 (9.1)%1,393 (25.5)%
Foreign rate differential(647)0.3 %236 (0.1)%116 (2.1)%
Stock based compensation806 (0.4)%145 — %— — %
Capital payments
1,465 (0.8)%— — %— — %
Rate Change(931)0.5 %247 (0.1)%— — %
Net impact of non-controlling interest7,363 (3.8)%1,363 (0.4)%— — %
Total Effective Rate$(21,133)10.8 %$(10,534)3.3 %$527 (9.6)%
Schedule of Deferred Tax Assets and Liabilities
As of December 31, 2024 and 2023 the income tax effects of temporary differences that give rise to significant portions of deferred tax assets and liabilities were as follows:
(Dollars in Thousands)December 31, 2024December 31, 2023
Deferred tax assets
Net operating losses$46,769 $23,273 
Investment in partnership15,321 7,158 
Goodwill1,503 201 
Disallowed interest carryforward8,337 4,376 
Accruals and reserves6,592 11,191 
Operating Lease Liability5,068 5,274 
Other deferred tax asset4,428 — 
Total deferred tax assets88,018 51,473 
Deferred tax liabilities
Intangibles$17,353 $17,649 
Operating Lease - Right Of Use5,047 5,299 
Investment in partnership— — 
Other deferred tax liability1,436 627 
Total deferred tax liabilities23,836 23,575 
Valuation allowance(53,654)(42,007)
Net deferred tax asset (liabilities)$10,528 $(14,109)
Schedule of Unrecognized Tax Benefits Roll Forward
The following table presents a reconciliation of the Company’s total gross unrecognized tax benefits for the year ended December 31, 2024 and 2023:

(Dollars in Thousands)December 31, 2024December 31, 2023
Balance at January 1,$— $— 
Additions, based on tax positions related to current year— — 
Additions for tax positions of prior years240 — 
Reduction for tax positions of prior years— — 
Settlements— — 
Lapses in statues of limitations— — 
Balance at December 31$240 $—